Stuttgart - Delayed Quote EUR
Axsome Therapeutics Inc (19X.SG)
90.74
-1.18
(-1.28%)
At close: April 22 at 9:12:23 PM GMT+2
Breakdown
TTM
12/31/2024
12/31/2023
12/31/2022
12/31/2021
Operating Cash Flow
-128,410
-128,410
-145,080
-116,511
-108,226
Investing Cash Flow
-270
-270
-582
-53,702
-308
Financing Cash Flow
57,840
57,840
331,013
284,582
11,130
End Cash Position
315,353
315,353
386,193
200,842
86,473
Interest Paid Supplemental Data
19,690
19,690
16,730
7,686
4,625
Capital Expenditure
-270
-270
-582
-702
-308
Issuance of Capital Stock
40,784
40,784
258,750
243,763
7,436
Issuance of Debt
--
--
85,000
45,000
--
Repayment of Debt
-990
-990
--
--
--
Free Cash Flow
-128,680
-128,680
-145,662
-117,213
-108,534
12/31/2021 - 8/28/2017
Upgrade to begin using 40 years of financial statements and get so much more.
Perform in-depth fundamental analysis with decades of income statements, balance sheets, and cash flows — all exportable.
UpgradeRelated Tickers
96X.F FluoGuide A/S
3.3000
+4.10%
ACE.ST Ascelia Pharma AB (publ)
3.1750
+2.75%
PILA.ST Pila Pharma AB (publ)
3.2400
-6.49%
207940.KS Samsung Biologics Co.,Ltd.
1,056,000.00
-1.77%
NGEN.V NervGen Pharma Corp.
2.9500
0.00%
EXPRS2.ST ExpreS2ion Biotech Holding AB (publ)
19.40
+2.21%
OXB.L Oxford Biomedica plc
303.50
+1.51%
ALK-B.CO ALK-Abelló A/S
144.10
-3.03%
YMAB Y-mAbs Therapeutics, Inc.
4.2600
-11.62%
ASND Ascendis Pharma A/S
159.13
-1.25%